Boehringer plans to again increase R&D spending; Valneva, Pfizer to advance Lyme vaccine candidate

Plus, news about OP­KO, Health­Care Roy­al­ty, In­ven­ti­va, Ex­sci­en­tia and GT Ape­iron:

Boehringer In­gel­heim ups its R&D bud­get: Back in April, the com­pa­ny said it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.